These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 25905926

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities.
    Krajewski KM, Braschi-Amirfarzan M, DiPiro PJ, Jagannathan JP, Shinagare AB.
    Korean J Radiol; 2017; 18(1):28-41. PubMed ID: 28096716
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Targeted therapy and elderly people: A review.
    Daste A, Chakiba C, Domblides C, Gross-Goupil M, Quivy A, Ravaud A, Soubeyran P.
    Eur J Cancer; 2016 Dec; 69():199-215. PubMed ID: 27855351
    [Abstract] [Full Text] [Related]

  • 7. Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN).
    Launay-Vacher V, Aapro M, De Castro G, Cohen E, Deray G, Dooley M, Humphreys B, Lichtman S, Rey J, Scotté F, Wildiers H, Sprangers B.
    Ann Oncol; 2015 Aug; 26(8):1677-84. PubMed ID: 25735315
    [Abstract] [Full Text] [Related]

  • 8. Pancreatic neuroendocrine tumors: targeting the molecular basis of disease.
    Khagi S, Saif MW.
    Curr Opin Oncol; 2015 Jan; 27(1):38-43. PubMed ID: 25390554
    [Abstract] [Full Text] [Related]

  • 9. [Tyrosine kinase inhibitors in tumor therapy--part 2. Current position and perspectives].
    Grimm CF, Blum HE, Geissler M.
    Dtsch Med Wochenschr; 2005 Jun 10; 130(23):1438-42. PubMed ID: 15929020
    [No Abstract] [Full Text] [Related]

  • 10. Targeted therapy in older patients with solid tumors.
    Kelly CM, Power DG, Lichtman SM.
    J Clin Oncol; 2014 Aug 20; 32(24):2635-46. PubMed ID: 25071113
    [Abstract] [Full Text] [Related]

  • 11. Novel chemotherapeutic approaches in adult high-grade gliomas.
    Jordan JT, Wen PY.
    Cancer Treat Res; 2015 Aug 20; 163():117-42. PubMed ID: 25468229
    [Abstract] [Full Text] [Related]

  • 12. Successful targeted therapies for hepatocellular carcinoma: are we really getting there?
    Zhu AX.
    Expert Rev Anticancer Ther; 2008 Apr 20; 8(4):499-505. PubMed ID: 18402516
    [No Abstract] [Full Text] [Related]

  • 13. [mTOR inhibitor].
    Muro K.
    Gan To Kagaku Ryoho; 2011 Jan 20; 38(1):7-11. PubMed ID: 21368454
    [Abstract] [Full Text] [Related]

  • 14. Targeting the MET gene for the treatment of non-small-cell lung cancer.
    Gelsomino F, Facchinetti F, Haspinger ER, Garassino MC, Trusolino L, De Braud F, Tiseo M.
    Crit Rev Oncol Hematol; 2014 Feb 20; 89(2):284-99. PubMed ID: 24355409
    [Abstract] [Full Text] [Related]

  • 15. The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents.
    Tabernero J.
    Mol Cancer Res; 2007 Mar 20; 5(3):203-20. PubMed ID: 17374728
    [Abstract] [Full Text] [Related]

  • 16. Combination therapy in metastatic renal cell cancer.
    Ravaud A, Gross-Goupil M, Bellmunt J.
    Semin Oncol; 2013 Aug 20; 40(4):472-81. PubMed ID: 23972711
    [Abstract] [Full Text] [Related]

  • 17. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S, Djelloul S, Raymond E.
    Semin Oncol; 2006 Aug 20; 33(4):407-20. PubMed ID: 16890796
    [Abstract] [Full Text] [Related]

  • 18. Molecular signaling and the role of targeted therapies in bladder cancer.
    Black PC.
    Minerva Urol Nefrol; 2012 Mar 20; 64(1):7-17. PubMed ID: 22402314
    [Abstract] [Full Text] [Related]

  • 19. Clinical and molecular prognostic factors in renal cell carcinoma: what we know so far.
    Tang PA, Vickers MM, Heng DY.
    Hematol Oncol Clin North Am; 2011 Aug 20; 25(4):871-91. PubMed ID: 21763972
    [Abstract] [Full Text] [Related]

  • 20. Retrospective comparison of triple-sequence therapies in metastatic renal cell carcinoma.
    Busch J, Seidel C, Erber B, Issever AS, Hinz S, Kempkensteffen C, Magheli A, Miller K, Grünwald V, Weikert S.
    Eur Urol; 2013 Jul 20; 64(1):62-70. PubMed ID: 22999519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.